Congress Grills Major Drug Manufacturer on Anticompetitive Tactics and Price Gouging
Drug Prices
Congress Grills Major Drug Manufacturer on Anticompetitive Tactics and Price Gouging
Policies Take Aim at Rising Health Care Costs Hurting Families, Employers and Taxpayers
Commercial Sector Prices
Policies Take Aim at Rising Health Care Costs Hurting Families, Employers and Taxpayers
President Biden Called on Congress to Lower Drug Prices. What’s Next?
Drug Prices
President Biden Called on Congress to Lower Drug Prices. What’s Next?
New Laws Take Aim at Drug Prices, But Stronger Action Needed
Drug Prices
New Laws Take Aim at Drug Prices, But Stronger Action Needed
After Sluggish Start, Is the Biosimilar Market Poised for Growth?
Drug Prices
After Sluggish Start, Is the Biosimilar Market Poised for Growth?
Drug Pricing Reform Enters a Big, New Battleground: States
Drug Prices
Drug Pricing Reform Enters a Big, New Battleground: States
How One Colorado Organization Brought Down Health Care Prices
Commercial Sector Prices
How One Colorado Organization Brought Down Health Care Prices
Q&A
Landmark SCOTUS Ruling Opens the Door for Stronger State Regulation of PBMs
Drug Prices
Landmark SCOTUS Ruling Opens the Door for Stronger State Regulation of PBMs
A Drug is 90 Percent Effective at Preventing HIV. It Costs Up to $1,800 Per Month.
Drug Prices
A Drug is 90 Percent Effective at Preventing HIV. It Costs Up to $1,800 Per Month.
New Federal Reform Will Boost Organ Transplants, Saving Thousands of Lives
Organ Donation
New Federal Reform Will Boost Organ Transplants, Saving Thousands of Lives
CMS’ Proposed Rule on 'Breakthrough' Medical Devices Builds on a Flawed System
Provider Payment Incentives
CMS’ Proposed Rule on ‘Breakthrough’ Medical Devices Builds on a Flawed System
In Day 2 of Testimony, Pharma Execs Struggle to Answer Tough Questions on Unsustainable Drug Prices
Drug Prices
In Day 2 of Testimony, Pharma Execs Struggle to Answer Tough Questions on Unsustainable Drug Prices
Pharma’s Bad Behaviors Exposed in Congressional Testimony
Drug Prices
Pharma’s Bad Behaviors Exposed in Congressional Testimony
'Evergreening' Stunts Competition, Costs Consumers and Taxpayers
Drug Prices
‘Evergreening’ Stunts Competition, Costs Consumers and Taxpayers
Surprise Medical Billing Remains a Threat to Patients Amid Health, Economic Crisis
Commercial Sector Prices
Surprise Medical Billing Remains a Threat to Patients Amid Health, Economic Crisis
Broadly Used Data Source May Result in Inaccurate Estimates of Drug Prices
Drug Prices
Broadly Used Data Source May Result in Inaccurate Estimates of Drug Prices
To Lower Drug Costs, Tap Pharmacists for Help
Drug Prices
To Lower Drug Costs, Tap Pharmacists for Help
A Lesson from States: Curtailing Anticompetitive Health Care Consolidation
Commercial Sector Prices
A Lesson from States: Curtailing Anticompetitive Health Care Consolidation
A Reflection on the Biosimilar Pathway As it Turns 10 Years Old
Drug Prices
A Reflection on the Biosimilar Pathway As it Turns 10 Years Old
Texas Hospitals Sue Patients Over Medical Debt
Commercial Sector Prices
Texas Hospitals Sue Patients Over Medical Debt
Debunking Myths in the Surprise Billing Debate
Commercial Sector Prices
Debunking Myths in the Surprise Billing Debate
Medicare-Medicaid Integration
A Letter to the CMS on Medicare Advantage Plan Rules
Why Nonprofit Pharma, a Promising Fix for Drug Prices, Faces an Uphill Battle
Drug Prices
Why Nonprofit Pharma, a Promising Fix for Drug Prices, Faces an Uphill Battle
About Us
We strive to maximize opportunity and minimize injustice by investing in systemic solutions that will outlast our funding.
